Company intelligence / Profile preview

Echo Lake Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Echo Lake Capital, as a major shareholder, issued a proposal to acquire all shares of Quince Therapeutics at a 90% premium over market value in March 2023. It emphasized Quince’s lack of active drug development and its undervalued assets

Industry: Investors

Beyond the preview

Go deeper on Echo Lake Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Echo Lake Capital.

Explore the full profile